Physician
Kion Pediatrics
Kion Pediatrics was paid $3.88M by Medicaid between Jun 2019 and Dec 2024, across 62 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoKION PEDIATRICS
JONESBORO, AR 72401
JONESBORO, AR 72401
33aNPI1194282822assigned 02/28/2019
33bProvider typePediatrics Physician
28Total paid$3.88M
24GClaims140,408
24DCodes billed62
24AFirst – last monthJun 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Arkansas
Rank by total paid#8 of 108
Median peer was paid$225K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 8,206 | $190K | |
| 2020 | 18,144 | $410K | |
| 2021 | 25,538 | $682K | |
| 2022 | 26,127 | $878K | |
| 2023 | 27,017 | $825K | |
| 2024incomplete | 35,376 | $898K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 29,268 | 24,332 | $1.63M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 16,135 | 13,308 | $438K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.3% | 3,704 | 3,153 | $360K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7.0% | 6,841 | 5,782 | $273K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.0% | 4,967 | 4,229 | $233K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.6% | 3,629 | 3,099 | $177K |
| 87634 | 3.5% | 1,955 | 1,644 | $136K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.3% | 1,971 | 1,602 | $88K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.1% | 1,844 | 1,651 | $82K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 1,099 | 745 | $58K |
| 99381 | 1.2% | 1,323 | 830 | $48K | |
| 90648 | <1% | 2,811 | 2,477 | $34K |
50 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 897 | $32K |
| 90670 | <1% | 2,964 | $30K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 881 | $30K |
| 90723 | <1% | 2,572 | $26K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,292 | $26K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 202 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,281 | $14K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 309 | $14K |
| 90633 | <1% | 1,234 | $13K | |
| 90716 | <1% | 1,090 | $11K | |
| 90707 | <1% | 1,036 | $11K | |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 8,082 | $10K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 17,595 | $10K |
| 99382 | <1% | 424 | $10K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 929 | $10K |
| 99383 | <1% | 394 | $9K | |
| 90680 | <1% | 727 | $7K | |
| 90677 | <1% | 538 | $6K | |
| 96127 | <1% | 4,124 | $6K | |
| 90681 | <1% | 423 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 282 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 381 | $3K |
| 83655 | <1% | 296 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 277 | $3K |
| 90647 | <1% | 270 | $2K | |
| 99188 | <1% | 162 | $2K | |
| 87807 | <1% | 141 | $2K | |
| 90688 | <1% | 155 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 74 | $2K |
| 92552 | <1% | 84 | $1K | |
| 69210 | <1% | 99 | $1K | |
| 90700 | <1% | 100 | $1K | |
| 95117 | <1% | 83 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 114 | $904.56 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 90 | $892.37 |
| 90686 | <1% | 59 | $670.30 | |
| 90696 | <1% | 66 | $670.14 | |
| 80061 | Lipid panel | <1% | 44 | $534.31 |
| 81002 | <1% | 155 | $414.58 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 26 | $378.46 |
| 90734 | <1% | 31 | $367.82 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 26 | $177.60 |
| 96161 | <1% | 11,939 | $65.08 | |
| 94664 | <1% | 46 | $13.90 | |
| 94760 | <1% | 34 | $8.00 | |
| 97802 | <1% | 2,109 | $6.00 | |
| 96160 | 0% | 370 | $0.00 | |
| 99461 | 0% | 19 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 13 | $0.00 |
| 36416 | 0% | 322 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNWOKEJI, KRIS (PHYSICIAN)
| Provider | Location | Paid |
|---|---|---|
| Kion Pediatrics | Newport, AR | $225K |
| Kion Pediatrics | Paragould, AR | $162K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.